| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 20,700 | $30 | $703.8K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 104,800 | $1 | $419.2K |
| J3262 | Injection, tocilizumab, 1 mg | 63,000 | $10 | $315K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 6,600 | $30 | $171.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,630 | $90 | $141.7K |
| J0897 | Injection, denosumab, 1 mg | 4,560 | $20 | $86.6K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 7,350 | $10 | $80.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 580 | $90 | $54.6K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 290 | $50 | $15.3K |
| 20610 | In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may inject a… | 290 | $50 | $13.8K |